211 related articles for article (PubMed ID: 28236450)
21. Lead optimization at C-2 and N-3 positions of thiazolidin-4-ones as HIV-1 non-nucleoside reverse transcriptase inhibitors.
Murugesan V; Tiwari VS; Saxena R; Tripathi R; Paranjape R; Kulkarni S; Makwana N; Suryawanshi R; Katti SB
Bioorg Med Chem; 2011 Nov; 19(22):6919-26. PubMed ID: 21982685
[TBL] [Abstract][Full Text] [Related]
22. Revealing the drug-resistant mechanism for diarylpyrimidine analogue inhibitors of HIV-1 reverse transcriptase.
Zhang H; Qin F; Ye W; Li Z; Ma S; Xia Y; Jiang Y; Zhu J; Li Y; Zhang J; Chen HF
Chem Biol Drug Des; 2011 Sep; 78(3):427-37. PubMed ID: 21696545
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and HIV-1 RT inhibitory action of novel (4/6-substituted benzo[d]thiazol -2-yl)thiazolidin-4-ones. Divergence from the non-competitive inhibition mechanism.
Pitta E; Geronikaki A; Surmava S; Eleftheriou P; Mehta VP; Van der Eycken EV
J Enzyme Inhib Med Chem; 2013 Feb; 28(1):113-22. PubMed ID: 22380777
[TBL] [Abstract][Full Text] [Related]
24. Rational design and Structure-Activity relationship of coumarin derivatives effective on HIV-1 protease and partially on HIV-1 reverse transcriptase.
Zhu M; Ma L; Wen J; Dong B; Wang Y; Wang Z; Zhou J; Zhang G; Wang J; Guo Y; Liang C; Cen S; Wang Y
Eur J Med Chem; 2020 Jan; 186():111900. PubMed ID: 31771827
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of interaction of novel indolylarylsulfone derivatives with K103N and Y181I mutant HIV-1 reverse transcriptase in complex with its substrates.
Samuele A; Bisi S; Kataropoulou A; La Regina G; Piscitelli F; Gatti V; Silvestri R; Maga G
Antivir Chem Chemother; 2011 Nov; 22(3):107-18. PubMed ID: 22095519
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.
Chen X; Zhan P; Pannecouque C; Balzarini J; De Clercq E; Liu X
Eur J Med Chem; 2012 May; 51():60-6. PubMed ID: 22405288
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Bioorg Med Chem; 2007 May; 15(9):3134-42. PubMed ID: 17349793
[TBL] [Abstract][Full Text] [Related]
28. Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants.
Kang D; Fang Z; Huang B; Lu X; Zhang H; Xu H; Huo Z; Zhou Z; Yu Z; Meng Q; Wu G; Ding X; Tian Y; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
J Med Chem; 2017 May; 60(10):4424-4443. PubMed ID: 28481112
[TBL] [Abstract][Full Text] [Related]
29. Structure-based design of conformationally flexible reverse transcriptase inhibitors to combat resistant HIV.
Hao GF; Yang SG; Yang GF
Curr Pharm Des; 2014; 20(5):725-39. PubMed ID: 23688080
[TBL] [Abstract][Full Text] [Related]
30. Slow-, tight-binding HIV-1 reverse transcriptase non-nucleoside inhibitors highly active against drug-resistant mutants.
Cancio R; Mai A; Rotili D; Artico M; Sbardella G; Clotet-Codina I; Esté JA; Crespan E; Zanoli S; Hübscher U; Spadari S; Maga G
ChemMedChem; 2007 Apr; 2(4):445-8. PubMed ID: 17323401
[No Abstract] [Full Text] [Related]
31. New Efavirenz Derivatives and 1,2,3-Triazolyl-phosphonates as Inhibitors of Reverse Transcriptase of HIV-1.
Costa CCP; Boechat N; Bastos MM; da Silva FC; Marttorelli A; Souza TML; Baptista MS; Hoelz LVB; Cafffarena ER
Curr Top Med Chem; 2018; 18(17):1494-1505. PubMed ID: 30370848
[TBL] [Abstract][Full Text] [Related]
32. Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays.
Chen W; Zhan P; Rai D; De Clercq E; Pannecouque C; Balzarini J; Zhou Z; Liu H; Liu X
Bioorg Med Chem; 2014 Mar; 22(6):1863-72. PubMed ID: 24581546
[TBL] [Abstract][Full Text] [Related]
33. Comparative Docking Studies: A Drug Design Tool for Some Pyrazine- Thiazolidinone Based Derivatives for Anti-HIV Activity.
Asgaonkar KD; Patil SM; Chitre TS; Ghegade VN; Jadhav SR; Sande SS; Kulkarni AS
Curr Comput Aided Drug Des; 2019; 15(3):252-258. PubMed ID: 30569873
[TBL] [Abstract][Full Text] [Related]
34. Molecular docking, design, synthesis and biological evaluation of novel 2,3-aryl-thiazolidin-4-ones as potent NNRTIs.
Geronikaki A; Petrou A; Kartsev V; Eleftheriou P; Boga R; Bartolo B; Crespan E; Franco G; Maga G
SAR QSAR Environ Res; 2019 Oct; 30(10):697-714. PubMed ID: 31542957
[TBL] [Abstract][Full Text] [Related]
35. Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1.
Chan JH; Freeman GA; Tidwell JH; Romines KR; Schaller LT; Cowan JR; Gonzales SS; Lowell GS; Andrews CW; Reynolds DJ; St Clair M; Hazen RJ; Ferris RG; Creech KL; Roberts GB; Short SA; Weaver K; Koszalka GW; Boone LR
J Med Chem; 2004 Feb; 47(5):1175-82. PubMed ID: 14971897
[TBL] [Abstract][Full Text] [Related]
36. Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
Taylor DL; Ahmed PS; Chambers P; Tyms AS; Bedard J; Duchaine J; Falardeau G; Lavallée JF; Brown W; Rando RF; Bowlin T
Antivir Chem Chemother; 1999 Mar; 10(2):79-86. PubMed ID: 10335402
[TBL] [Abstract][Full Text] [Related]
37. The anti-HIV activity of three 2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4 (3H)-one derivatives acting as non-nucleoside reverse transcriptase inhibitor in vitro.
Long J; Zhang DH; Zhang GH; Rao ZK; Wang YH; Tam SC; He YP; Zheng YT
Yao Xue Xue Bao; 2010 Feb; 45(2):228-34. PubMed ID: 21348416
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and anti-HIV-1 RT evaluation of 2-(benzyl(4-chlorophenyl)amino)-1-(piperazin-1-yl)ethanone derivatives.
Chander S; Wang P; Ashok P; Yang LM; Zheng YT; Sankaranarayanan M
Bioorg Med Chem Lett; 2017 Jan; 27(1):61-65. PubMed ID: 27894873
[TBL] [Abstract][Full Text] [Related]
39. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of HIV-1 RT activity by a new series of 3-(1,3,4-thiadiazol-2-yl)thiazolidin-4-one derivatives.
Buemi MR; Gitto R; Ielo L; Pannecouque C; De Luca L
Bioorg Med Chem; 2020 Apr; 28(8):115431. PubMed ID: 32197813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]